The present application relates to combinations of inhibitors directed at down regulation of genes associated with hearing loss including HES1 HES5 HEY2 CDKN1B and NOTCH1 exhibiting a beneficial effect and useful in treating or attenuating hearing loss treating balance impairment promoting the replacement regeneration or protection of otic (sensory) hair cells of the inner ear and or effecting hearing restoration / regeneration.